High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies

Deciphering Developmental Disorders Study

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Developmental and epileptic encephalopathy (DEE) is a group of conditions characterized by the co-occurrence of epilepsy and intellectual disability (ID), typically with developmental plateauing or regression associated with frequent epileptiform activity. The cause of DEE remains unknown in the majority of cases. We performed whole-genome sequencing (WGS) in 197 individuals with unexplained DEE and pharmaco-resistant seizures and in their unaffected parents. We focused our attention on de novo mutations (DNMs) and identified candidate genes containing such variants. We sought to identify additional subjects with DNMs in these genes by performing targeted sequencing in another series of individuals with DEE and by mining various sequencing datasets. We also performed meta-analyses to document enrichment of DNMs in candidate genes by leveraging our WGS dataset with those of several DEE and ID series. By combining these strategies, we were able to provide a causal link between DEE and the following genes: NTRK2, GABRB2, CLTC, DHDDS, NUS1, RAB11A, GABBR2, and SNAP25. Overall, we established a molecular diagnosis in 63/197 (32%) individuals in our WGS series. The main cause of DEE in these individuals was de novo point mutations (53/63 solved cases), followed by inherited mutations (6/63 solved cases) and de novo CNVs (4/63 solved cases). De novo missense variants explained a larger proportion of individuals in our series than in other series that were primarily ascertained because of ID. Moreover, these DNMs were more frequently recurrent than those identified in ID series. These observations indicate that the genetic landscape of DEE might be different from that of ID without epilepsy.

Original languageEnglish (US)
Pages (from-to)664-685
Number of pages22
JournalAmerican Journal of Human Genetics
Volume101
Issue number5
DOIs
StatePublished - Nov 2 2017

Fingerprint

Brain Diseases
Mutation
Intellectual Disability
Genome
Genes
Epilepsy
Point Mutation
Meta-Analysis
Seizures

Keywords

  • CLTC
  • DHDDS
  • epileptic encephalopathy
  • GABBR2
  • GABRB2
  • NTRK2
  • NUS1
  • RAB11
  • SNAP25

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies. / Deciphering Developmental Disorders Study.

In: American Journal of Human Genetics, Vol. 101, No. 5, 02.11.2017, p. 664-685.

Research output: Contribution to journalArticle

Deciphering Developmental Disorders Study. / High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies. In: American Journal of Human Genetics. 2017 ; Vol. 101, No. 5. pp. 664-685.
@article{0deefbeee8aa40dbb44db57c350f8952,
title = "High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies",
abstract = "Developmental and epileptic encephalopathy (DEE) is a group of conditions characterized by the co-occurrence of epilepsy and intellectual disability (ID), typically with developmental plateauing or regression associated with frequent epileptiform activity. The cause of DEE remains unknown in the majority of cases. We performed whole-genome sequencing (WGS) in 197 individuals with unexplained DEE and pharmaco-resistant seizures and in their unaffected parents. We focused our attention on de novo mutations (DNMs) and identified candidate genes containing such variants. We sought to identify additional subjects with DNMs in these genes by performing targeted sequencing in another series of individuals with DEE and by mining various sequencing datasets. We also performed meta-analyses to document enrichment of DNMs in candidate genes by leveraging our WGS dataset with those of several DEE and ID series. By combining these strategies, we were able to provide a causal link between DEE and the following genes: NTRK2, GABRB2, CLTC, DHDDS, NUS1, RAB11A, GABBR2, and SNAP25. Overall, we established a molecular diagnosis in 63/197 (32{\%}) individuals in our WGS series. The main cause of DEE in these individuals was de novo point mutations (53/63 solved cases), followed by inherited mutations (6/63 solved cases) and de novo CNVs (4/63 solved cases). De novo missense variants explained a larger proportion of individuals in our series than in other series that were primarily ascertained because of ID. Moreover, these DNMs were more frequently recurrent than those identified in ID series. These observations indicate that the genetic landscape of DEE might be different from that of ID without epilepsy.",
keywords = "CLTC, DHDDS, epileptic encephalopathy, GABBR2, GABRB2, NTRK2, NUS1, RAB11, SNAP25",
author = "{Deciphering Developmental Disorders Study} and Hamdan, {Fadi F.} and Myers, {Candace T.} and Patrick Cossette and Philippe Lemay and Dan Spiegelman and Laporte, {Alexandre Dionne} and Christina Nassif and Ousmane Diallo and Jean Monlong and Maxime Cadieux-Dion and Sylvia Dobrzeniecka and Caroline Meloche and Kyle Retterer and Cho, {Megan T.} and Rosenfeld, {Jill A.} and Weimin Bi and Christine Massicotte and Marguerite Miguet and Ledia Brunga and Regan, {Brigid M.} and Kelly Mo and Cory Tam and Amy Schneider and Georgie Hollingsworth and FitzPatrick, {David R.} and Alan Donaldson and Natalie Canham and Edward Blair and Bronwyn Kerr and Fry, {Andrew E.} and Thomas, {Rhys H.} and Joss Shelagh and Hurst, {Jane A.} and Helen Brittain and Moira Blyth and Lebel, {Robert Roger} and Gerkes, {Erica H.} and Laura Davis-Keppen and Quinn Stein and Chung, {Wendy K.} and Dorison, {Sara J.} and Benke, {Paul J.} and Emily Fassi and Nicole Corsten-Janssen and Kamsteeg, {Erik Jan} and Mau-Them, {Frederic T.} and Bruel, {Ange Line} and Alain Verloes and Katrin {\~O}unap and Minassian, {Berge A.}",
year = "2017",
month = "11",
day = "2",
doi = "10.1016/j.ajhg.2017.09.008",
language = "English (US)",
volume = "101",
pages = "664--685",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies

AU - Deciphering Developmental Disorders Study

AU - Hamdan, Fadi F.

AU - Myers, Candace T.

AU - Cossette, Patrick

AU - Lemay, Philippe

AU - Spiegelman, Dan

AU - Laporte, Alexandre Dionne

AU - Nassif, Christina

AU - Diallo, Ousmane

AU - Monlong, Jean

AU - Cadieux-Dion, Maxime

AU - Dobrzeniecka, Sylvia

AU - Meloche, Caroline

AU - Retterer, Kyle

AU - Cho, Megan T.

AU - Rosenfeld, Jill A.

AU - Bi, Weimin

AU - Massicotte, Christine

AU - Miguet, Marguerite

AU - Brunga, Ledia

AU - Regan, Brigid M.

AU - Mo, Kelly

AU - Tam, Cory

AU - Schneider, Amy

AU - Hollingsworth, Georgie

AU - FitzPatrick, David R.

AU - Donaldson, Alan

AU - Canham, Natalie

AU - Blair, Edward

AU - Kerr, Bronwyn

AU - Fry, Andrew E.

AU - Thomas, Rhys H.

AU - Shelagh, Joss

AU - Hurst, Jane A.

AU - Brittain, Helen

AU - Blyth, Moira

AU - Lebel, Robert Roger

AU - Gerkes, Erica H.

AU - Davis-Keppen, Laura

AU - Stein, Quinn

AU - Chung, Wendy K.

AU - Dorison, Sara J.

AU - Benke, Paul J.

AU - Fassi, Emily

AU - Corsten-Janssen, Nicole

AU - Kamsteeg, Erik Jan

AU - Mau-Them, Frederic T.

AU - Bruel, Ange Line

AU - Verloes, Alain

AU - Õunap, Katrin

AU - Minassian, Berge A.

PY - 2017/11/2

Y1 - 2017/11/2

N2 - Developmental and epileptic encephalopathy (DEE) is a group of conditions characterized by the co-occurrence of epilepsy and intellectual disability (ID), typically with developmental plateauing or regression associated with frequent epileptiform activity. The cause of DEE remains unknown in the majority of cases. We performed whole-genome sequencing (WGS) in 197 individuals with unexplained DEE and pharmaco-resistant seizures and in their unaffected parents. We focused our attention on de novo mutations (DNMs) and identified candidate genes containing such variants. We sought to identify additional subjects with DNMs in these genes by performing targeted sequencing in another series of individuals with DEE and by mining various sequencing datasets. We also performed meta-analyses to document enrichment of DNMs in candidate genes by leveraging our WGS dataset with those of several DEE and ID series. By combining these strategies, we were able to provide a causal link between DEE and the following genes: NTRK2, GABRB2, CLTC, DHDDS, NUS1, RAB11A, GABBR2, and SNAP25. Overall, we established a molecular diagnosis in 63/197 (32%) individuals in our WGS series. The main cause of DEE in these individuals was de novo point mutations (53/63 solved cases), followed by inherited mutations (6/63 solved cases) and de novo CNVs (4/63 solved cases). De novo missense variants explained a larger proportion of individuals in our series than in other series that were primarily ascertained because of ID. Moreover, these DNMs were more frequently recurrent than those identified in ID series. These observations indicate that the genetic landscape of DEE might be different from that of ID without epilepsy.

AB - Developmental and epileptic encephalopathy (DEE) is a group of conditions characterized by the co-occurrence of epilepsy and intellectual disability (ID), typically with developmental plateauing or regression associated with frequent epileptiform activity. The cause of DEE remains unknown in the majority of cases. We performed whole-genome sequencing (WGS) in 197 individuals with unexplained DEE and pharmaco-resistant seizures and in their unaffected parents. We focused our attention on de novo mutations (DNMs) and identified candidate genes containing such variants. We sought to identify additional subjects with DNMs in these genes by performing targeted sequencing in another series of individuals with DEE and by mining various sequencing datasets. We also performed meta-analyses to document enrichment of DNMs in candidate genes by leveraging our WGS dataset with those of several DEE and ID series. By combining these strategies, we were able to provide a causal link between DEE and the following genes: NTRK2, GABRB2, CLTC, DHDDS, NUS1, RAB11A, GABBR2, and SNAP25. Overall, we established a molecular diagnosis in 63/197 (32%) individuals in our WGS series. The main cause of DEE in these individuals was de novo point mutations (53/63 solved cases), followed by inherited mutations (6/63 solved cases) and de novo CNVs (4/63 solved cases). De novo missense variants explained a larger proportion of individuals in our series than in other series that were primarily ascertained because of ID. Moreover, these DNMs were more frequently recurrent than those identified in ID series. These observations indicate that the genetic landscape of DEE might be different from that of ID without epilepsy.

KW - CLTC

KW - DHDDS

KW - epileptic encephalopathy

KW - GABBR2

KW - GABRB2

KW - NTRK2

KW - NUS1

KW - RAB11

KW - SNAP25

UR - http://www.scopus.com/inward/record.url?scp=85033604759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033604759&partnerID=8YFLogxK

U2 - 10.1016/j.ajhg.2017.09.008

DO - 10.1016/j.ajhg.2017.09.008

M3 - Article

VL - 101

SP - 664

EP - 685

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 5

ER -